Market Snapshot & Technical Readiness Benchmarks
The New York healthcare and biotech PR segment is narrow, crowded, and technically uneven. Our verified dataset covers 11 agencies, all headquartered in New York, with an average Pytch Score of 48/100. That average is the headline: half of the field, roughly, is doing the operational work that separates a functional agency from a well-pitched one. The other half is coasting on relationships and category reputation.
Three benchmarks matter most for buyers in regulated healthcare and biotech:
Email deliverability and DMARC. 73% of the field publishes a DMARC record. That means roughly one in four agencies you shortlist cannot demonstrate basic control over its own outbound mail infrastructure — the same infrastructure it will use to pitch journalists on your behalf. Deliverability scores across the dataset range from 10 (Pollock Communications) to 96 (G&S Integrated Marketing Communications Group). A low score here is not a branding problem; it is a pitch-placement risk. If your agency's domain lands in spam, your announcement does not exist.
Dedicated newsroom adoption. Only 18% of the field — two agencies — maintains a dedicated newsroom. For healthcare and biotech buyers, this is a measurable gap. Journalists covering FDA clearances, trial readouts, and payer decisions need a stable, indexed source of record. An agency without a newsroom is asking reporters to work from email threads and PDFs.
Domain authority. Estimated DR clusters tightly between 20 and 22 across ten of eleven agencies, with Butler Associates at 20. This is a floor, not a differentiator. Do not let a proposal sell you on "high-authority placements" when the agency's own domain sits at 22. Ask instead about the authority of the specific outlets it has actually placed clients in.
The practical read: in this segment, technical readiness is the cheapest signal you can screen on, and it correlates with operational discipline more broadly. An agency that has not configured DMARC in 2026 is an agency that has not audited its own processes.
Top Listed Agencies Compared
The table below summarizes nine of the eleven verified agencies. Scores are drawn directly from the live directory data. Retainers are listed as "Custom / Undisclosed" where the agency does not publish pricing — which is every agency in this segment.
| Agency | Pytch Score | Deliverability | DMARC | Newsroom | Est. DR | Notable Clients (per listing) |
|---|---|---|---|---|---|---|
| marinopr.com | 63 | 90 | Yes | Yes | 20 | Curaleaf, VTS, Bono, Chelsea Market, etain |
| Attention Comms, Inc. | 55 | 63 | Yes | Yes | 22 | — |
| G&S Integrated Marketing Communications Group | 52 | 96 | Yes | No | 22 | — |
| sureoak.com | 51 | 67 | Yes | No | 22 | — |
| topbrand.co | 51 | 49 | Yes | No | 22 | PepsiCo, Pfizer, Dior, Samsung, Land Rover |
| Havas Health & You | 50 | 85 | Yes | No | 22 | — |
| BOLD PR | 46 | 48 | Yes | No | 22 | — |
| SolComms | 46 | 49 | Yes | No | 22 | — |
| Butler Associates | 43 | 25 | No | No | 20 | NYS Correctional Officers PBA |
| Pollock Communications | 38 | 10 | No | No | 22 | Cranberry Institute, Danone North America, Tea Council of the USA, USA Pulses, USA Rice Federation |
Two agencies in the dataset are not shown above but complete the field of eleven: both are New York-based and fall within the same score band.
Read the table in two passes. First, filter on the operational columns — DMARC, newsroom, deliverability. marinopr.com and Attention Comms are the only two agencies clearing both the DMARC and newsroom bars, and marinopr.com pairs that with a 90 deliverability score. Second, read the client column for category fit. topbrand.co lists Pfizer among its clients, which is the strongest healthcare-adjacent brand signal in the dataset, but its deliverability score of 49 sits in the bottom third. Pollock Communications lists a deep bench of food and nutrition trade organizations — Cranberry Institute, USA Rice Federation, USA Pulses — which is a real specialty, but its deliverability score of 10 and absent DMARC record make it a hard sell for a company whose announcements need to land on deadline.
Havas Health & You is the purest healthcare specialist in the field, listing Healthcare & Biotech as its only niche, with a strong 85 deliverability score. G&S Integrated Marketing Communications Group posts the highest deliverability in the dataset at 96, but carries no newsroom and lists no clients. Butler Associates is the only agency in the field offering crisis and reputation management as a listed service — relevant for biotech firms facing clinical holds or safety events — but its 25 deliverability score and missing DMARC record are material weaknesses.
Retainer Economics: What You Actually Pay For
The typical market retainer range for this segment is $6,500 to $22,000 per month. Every agency in the dataset lists its retainer as "Custom / Undisclosed," which is standard practice and also a negotiating posture. The published range is the real signal: it tells you what the market bears and where the tiers sit.
The $6,500–$9,000 band. This buys a defined program: one to two senior practitioners, a media list, a monthly cadence of pitches, and basic reporting. At this level you are buying execution capacity, not strategy. Expect the agency to work from your messaging rather than build it. For a seed-stage biotech with a single scientific founder and one announcement per quarter, this band is usually sufficient — provided the agency clears the technical benchmarks above.
The $9,000–$15,000 band. This is the working middle of the New York market. You should get a dedicated account lead, a named media relations specialist, proactive pitching beyond your own news, executive visibility work, and some content or byline production. This is where most Series A and Series B healthcare companies land. Ask specifically how many hours per month the account lead allocates to your program and whether that person is shared across more than four accounts.
The $15,000–$22,000 band. At the top of the published range, you are buying senior counsel, category strategy, and often integrated support across media, executive communications, and digital. For a public biotech or a late-stage company with regulatory milestones, this is defensible. For a company with two announcements a year, it is overbuying.
Three cost structures to interrogate in any proposal:
- Retainer vs. project. Agencies in this segment default to retainer because it smooths their revenue. If your news flow is lumpy — a trial readout in Q2, a financing in Q4 — negotiate a project fee for the announcement and a smaller advisory retainer between events.
- Pass-through costs. Media monitoring, wire distribution, and database subscriptions are frequently billed on top of retainer. Ask for a written cap.
- Term and notice. Twelve-month terms with 90-day notice are common and rarely in your interest. Push for six months with 30-day notice in the first year.
The absence of published pricing across all eleven agencies is not an accident. It preserves the agency's ability to price to your funding stage rather than its own cost base. Come to the first call with a number and a scope; you will get a faster, more honest response than asking "what do you charge."
Agency vs. Self-Serve AI PR Outreach (When to Hire vs. Use Pytch at $29/run or $99/mo)
The honest framing: most healthcare and biotech companies need both, sequenced correctly.
Use self-serve outreach when the job is distribution. If you have a press release, a data readout, or a funding announcement and you need it in front of a defined list of journalists, Pytch at $29 per run or $99 per month does that work at a fraction of a retainer. A single $99 month covers more send volume than most $6,500 retainers allocate to any one client. For companies with fewer than four announcements a year, self-serve is the rational default. You keep control of the list, the timing, and the message.
Hire an agency when the job is relationship capital. Healthcare and biotech coverage is not won by volume. It is won by a reporter at a trade outlet or a national health desk trusting that your spokesperson will be responsive, accurate, and worth quoting again. That trust is built over months of unglamorous work: briefing calls, background conversations, and knowing which editor is on parental leave. No outreach tool replicates it. The agencies in this dataset with the strongest operational scores — marinopr.com at 63, Attention Comms at 55 — are selling exactly that accumulated access.
The hybrid pattern that works. Run self-serve outreach for routine distribution and list hygiene, and retain an agency for the two or three moments a year when relationship capital determines the outcome: a key trial readout, a regulatory decision, a leadership transition. This structure typically lands between $3,000 and $6,000 per month in agency fees plus a modest self-serve budget, well below the $6,500 floor of a full retainer.
When to skip the agency entirely. Pre-revenue companies, companies with no named spokesperson, and companies whose only news is internal should not be paying retainers. Fix the fundamentals first. A $99 monthly self-serve subscription plus a disciplined media list will outperform a $6,500 retainer spent on an agency pitching a story you have not yet earned.
One caution on the AI side: deliverability is the whole game. Before you run any outreach, confirm your own domain publishes DMARC. The 27% of agencies in this dataset without it are a useful warning — if professional firms skip this step, your in-house setup probably has too.
Step-by-Step Evaluation & RFP Checklist
Use these ten questions in writing. Require written answers before the pitch meeting; verbal answers in a room are worth less than a paragraph in an email.
- What is your DMARC policy, and can you send us the raw record? This is a two-minute check that filters the field. Three of eleven agencies in this dataset fail it.
- Do you maintain a dedicated newsroom for clients, and can we see a live example? Only 18% of this field can answer yes. Ask for the URL and check whether it is indexed and current.
- Which named practitioners will work on our account, and what percentage of their time is allocated to us? Get names, titles, and allocation percentages in the proposal. Reject "senior team" language without names.
- Show us three placements in healthcare or biotech trade press from the last twelve months, with outlet, date, and the reporter who wrote them. Verify each one. Ask what the pitch angle was and who initiated it.
- How do you handle regulatory and compliance review of materials? For biotech, ask specifically about MLR (medical, legal, regulatory) review timelines and whether the agency has in-house capability or relies on your team.
- What is your crisis protocol, and who is on call? Butler Associates is the only agency in this dataset listing crisis and reputation management as a service. If your agency does not list it, ask who they call.
- What is the reporting cadence, and what metrics appear in the report? Push past impressions and share-of-voice. Ask for pitch volume, response rate, and placement quality tiering.
- What is the term, notice period, and exit clause? Get the exact language. Ask what happens to work in progress if you terminate.
- What is the all-in monthly cost including pass-throughs, and what is the cap? Require a written cap on monitoring, wire, and database fees.
- Can you provide two client references in our exact subsector — not adjacent — who will take a call? Healthcare and biotech are broad. A diagnostics client reference tells you little about a therapeutics program.
Score each response. An agency that answers eight of ten in writing with specifics is a serious candidate. An agency that answers four and promises the rest "in the kickoff" is telling you how it will operate for the length of the contract.
Red Flags in PR Agency Proposals
Deliverability weakness dressed as strategy. An agency with a deliverability score in the 40s or below — topbrand.co at 49, BOLD PR at 48, SolComms at 49, Butler Associates at 25, Pollock Communications at 10 — will tell you its strength is relationships, not infrastructure. Sometimes that is true. But ask how pitches actually reach inboxes. If the answer is a personal Gmail, walk away.
Missing DMARC framed as a legacy issue. Two agencies in this dataset have no DMARC record. There is no legitimate technical reason for this in 2026. It is a configuration decision, and its absence signals that no one has audited outbound mail in years.
Client logos without context. topbrand.co lists Pfizer, PepsiCo, Samsung, and Land Rover. That is an impressive list. It does not tell you what work was done, at what scale, or by whom. Ask for the scope of each engagement and the name of the practitioner who led it. A logo wall is a marketing asset, not evidence.
No newsroom and no plan to build one. Nine of eleven agencies in this field lack a dedicated newsroom. If the agency cannot show you where its clients' news lives, ask how it expects journalists to find yours.
Retainer inflation without scope. A proposal at $18,000 per month with a scope that reads like a $9,000 program is a pricing problem, not a strategy problem. Itemize the scope against hours and deliverables before you negotiate on price.
Guaranteed coverage language. No credible agency guarantees placements in healthcare and biotech trade press. If a proposal contains a placement guarantee, the agency is either buying placements through paid channels or planning to underdeliver. Both outcomes cost you.
Vague reporting and no baseline. A proposal that does not include a measurement baseline in month one cannot demonstrate impact in month six. Ask what the baseline metrics will be and who sets them.
Single-practitioner dependency. If the entire pitch is delivered by one person and the proposal names no backup, you are buying a freelancer with an agency's overhead. Ask what happens when that person is on leave or leaves the firm.
No sector-specific compliance fluency. Healthcare and biotech carry disclosure rules, embargo norms around trial data, and reporter sensitivities that generalist agencies underestimate. An agency whose only healthcare client is a consumer wellness brand is not a healthcare agency. Ask for the specific regulatory and clinical contexts its team has worked in, and verify against the client list.
The field in New York is small enough to evaluate exhaustively. Eleven agencies, one city, a published retainer range of $6,500 to $22,000. The technical benchmarks — DMARC at 73%, newsrooms at 18%, average Pytch Score at 48 — tell you most of the field is competent at pitching and uneven at operations. Screen on operations first, then on sector fit, then on price. That order will save you a year.